CU6 0.00% $5.20 clarity pharmaceuticals ltd

Ann: IND approval from the FDA for theranostic SAR-Bombesin trial

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.